• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雪貂中 SARS-CoV-2 感染的年龄依赖性发病特征。

Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.

机构信息

College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea.

Zoonotic Infectious Diseases Research Center, Chungbuk National University, Cheongju, Korea.

出版信息

Nat Commun. 2022 Jan 10;13(1):21. doi: 10.1038/s41467-021-27717-3.

DOI:10.1038/s41467-021-27717-3
PMID:35013229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8748994/
Abstract

While the seroprevalence of SARS-CoV-2 in healthy people does not differ significantly among age groups, those aged 65 years or older exhibit strikingly higher COVID-19 mortality compared to younger individuals. To further understand differing COVID-19 manifestations in patients of different ages, three age groups of ferrets are infected with SARS-CoV-2. Although SARS-CoV-2 is isolated from all ferrets regardless of age, aged ferrets (≥3 years old) show higher viral loads, longer nasal virus shedding, and more severe lung inflammatory cell infiltration, and clinical symptoms compared to juvenile (≤6 months) and young adult (1-2 years) groups. Furthermore, direct contact ferrets co-housed with the virus-infected aged group shed more virus than direct-contact ferrets co-housed with virus-infected juvenile or young adult ferrets. Transcriptome analysis of aged ferret lungs reveals strong enrichment of gene sets related to type I interferon, activated T cells, and M1 macrophage responses, mimicking the gene expression profile of severe COVID-19 patients. Thus, SARS-CoV-2-infected aged ferrets highly recapitulate COVID-19 patients with severe symptoms and are useful for understanding age-associated infection, transmission, and pathogenesis of SARS-CoV-2.

摘要

虽然健康人群中 SARS-CoV-2 的血清流行率在不同年龄组之间没有显著差异,但 65 岁及以上人群的 COVID-19 死亡率明显高于年轻人群。为了进一步了解不同年龄患者 COVID-19 表现的差异,我们用 SARS-CoV-2 感染了三组年龄不同的雪貂。尽管无论年龄大小,所有雪貂都能分离到 SARS-CoV-2,但与幼龄(≤6 个月)和青年龄(1-2 岁)组相比,老龄(≥3 岁)雪貂的病毒载量更高,鼻病毒排出时间更长,肺部炎症细胞浸润更严重,临床症状也更严重。此外,与感染病毒的幼龄或青年龄雪貂直接接触的雪貂,其病毒排出量多于与感染病毒的老龄雪貂直接接触的雪貂。老龄雪貂肺部的转录组分析显示,与 I 型干扰素、激活的 T 细胞和 M1 巨噬细胞反应相关的基因集明显富集,与严重 COVID-19 患者的基因表达谱相似。因此,感染 SARS-CoV-2 的老龄雪貂高度重现了有严重症状的 COVID-19 患者,有助于了解 SARS-CoV-2 感染、传播和发病机制与年龄的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/443cf4e9ee9b/41467_2021_27717_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/9d4e7f07eebf/41467_2021_27717_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/925a24f438ac/41467_2021_27717_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/19a2651fd48a/41467_2021_27717_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/c58fbc31d31e/41467_2021_27717_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/73e034a833b4/41467_2021_27717_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/443cf4e9ee9b/41467_2021_27717_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/9d4e7f07eebf/41467_2021_27717_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/925a24f438ac/41467_2021_27717_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/19a2651fd48a/41467_2021_27717_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/c58fbc31d31e/41467_2021_27717_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/73e034a833b4/41467_2021_27717_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1380/8748994/443cf4e9ee9b/41467_2021_27717_Fig6_HTML.jpg

相似文献

1
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.雪貂中 SARS-CoV-2 感染的年龄依赖性发病特征。
Nat Commun. 2022 Jan 10;13(1):21. doi: 10.1038/s41467-021-27717-3.
2
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.雪貂感染新型冠状病毒2的年龄依赖性致病特征
Res Sq. 2021 Mar 29:rs.3.rs-131380. doi: 10.21203/rs.3.rs-131380/v2.
3
Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.年龄相关的雪貂对 SARS-CoV-2 感染的易感性。
J Virol. 2022 Feb 9;96(3):e0145521. doi: 10.1128/JVI.01455-21. Epub 2021 Nov 24.
4
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.中和抗体在 SARS-CoV-2 再感染和传播中的关键作用。
Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352.
5
Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.用 SARS-CoV-2 美国-WA1/2020 参考分离株的雪貂模型中传播和防止再感染。
J Virol. 2021 Jun 10;95(13):e0223220. doi: 10.1128/JVI.02232-20.
6
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.仓鼠和雪貂经鼻腔感染低剂量单株 SARS-CoV-2 的实验感染。
J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001567. Epub 2021 Feb 19.
7
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.雪貂中 SARS-CoV-2 的感染和快速传播。
Cell Host Microbe. 2020 May 13;27(5):704-709.e2. doi: 10.1016/j.chom.2020.03.023. Epub 2020 Apr 6.
8
Experimental re-infected cats do not transmit SARS-CoV-2.实验性再感染的猫不会传播 SARS-CoV-2。
Emerg Microbes Infect. 2021 Dec;10(1):638-650. doi: 10.1080/22221751.2021.1902753.
9
Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.新型冠状病毒肺炎(COVID-19)患者体内针对 SARS-CoV-2 的中和抗体反应的发展。
J Med Virol. 2021 Jul;93(7):4334-4341. doi: 10.1002/jmv.26939. Epub 2021 Mar 25.
10
SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.SARS-CoV-2 和甲型流感病毒在雪貂中的合并感染。
J Virol. 2022 Mar 9;96(5):e0179121. doi: 10.1128/JVI.01791-21. Epub 2021 Dec 22.

引用本文的文献

1
SARS-CoV-2 infection results in a unique lung proteome long after virus resolution in the hamster.在仓鼠体内,SARS-CoV-2感染在病毒清除很久之后会导致独特的肺部蛋白质组。
Npj Viruses. 2024 Aug 24;2(1):40. doi: 10.1038/s44298-024-00049-x.
2
Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model.探索老年人中重症新型冠状病毒肺炎的生物学机制:来自老年小鼠模型的见解
Virulence. 2025 Dec;16(1):2487671. doi: 10.1080/21505594.2025.2487671. Epub 2025 Apr 14.
3
Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models.

本文引用的文献

1
Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster.性别与叙利亚仓鼠感染 SARS-CoV-2 的易感性和发病机制有关。
Signal Transduct Target Ther. 2021 Mar 31;6(1):136. doi: 10.1038/s41392-021-00552-0.
2
SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance.SARS-CoV 和 SARS-CoV-2 通过空气在雪貂之间传播,传播距离超过一米。
Nat Commun. 2021 Mar 12;12(1):1653. doi: 10.1038/s41467-021-21918-6.
3
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.
动力学激活纳米疫苗模拟自然感染的多维免疫调节,在动物模型中对异源病毒具有广泛的保护作用。
Nat Commun. 2025 Mar 25;16(1):2914. doi: 10.1038/s41467-025-58006-y.
4
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
5
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives.肿瘤转移的机制洞察与治疗干预:最新进展与展望
Signal Transduct Target Ther. 2024 Aug 2;9(1):192. doi: 10.1038/s41392-024-01885-2.
6
A New Methodology for the Oxygen Measurement in Lung Tissue of an Aged Ferret Model Proves Hypoxia during COVID-19.一种用于老年雪貂模型肺组织中氧气测量的新方法证明了新冠病毒感染期间存在缺氧情况。
Am J Respir Cell Mol Biol. 2024 Aug;71(2):146-153. doi: 10.1165/rcmb.2024-0005MA.
7
Decisive reversal of lethal coronavirus disease 2019 in senescent hamster by synchronic antiviral and immunoregulatory intervention.通过同步抗病毒和免疫调节干预决定性逆转衰老仓鼠的致死性2019冠状病毒病
MedComm (2020). 2024 Jul 19;5(8):e642. doi: 10.1002/mco2.642. eCollection 2024 Aug.
8
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.在雪貂模型中,没有证据表明人多克隆 SARS-CoV-2 抗体增强疾病。
PLoS One. 2024 Jun 20;19(6):e0290909. doi: 10.1371/journal.pone.0290909. eCollection 2024.
9
Age-specific nasal epithelial responses to SARS-CoV-2 infection.特定年龄段鼻上皮对 SARS-CoV-2 感染的反应。
Nat Microbiol. 2024 May;9(5):1293-1311. doi: 10.1038/s41564-024-01658-1. Epub 2024 Apr 15.
10
SARS-CoV-2 immunity in animal models.动物模型中的 SARS-CoV-2 免疫。
Cell Mol Immunol. 2024 Feb;21(2):119-133. doi: 10.1038/s41423-023-01122-w. Epub 2024 Jan 18.
雪貂模型中感染 SARS-CoV-2 的剂量依赖性反应和保护性免疫的证据。
Nat Commun. 2021 Jan 4;12(1):81. doi: 10.1038/s41467-020-20439-y.
4
A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters.儿童在严重急性呼吸综合征冠状病毒 2 家庭传播集群中的作用的荟萃分析。
Clin Infect Dis. 2021 Jun 15;72(12):e1146-e1153. doi: 10.1093/cid/ciaa1825.
5
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.COVID-19 患者中嗅黏膜 SARS-CoV-2 入侵作为中枢神经系统进入的途径。
Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. Epub 2020 Nov 30.
6
Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques.老年 SARS-CoV-2 感染的非洲绿猴出现急性呼吸窘迫,但恒河猴没有。
Am J Pathol. 2021 Feb;191(2):274-282. doi: 10.1016/j.ajpath.2020.10.016. Epub 2020 Nov 7.
7
Age-specific mortality and immunity patterns of SARS-CoV-2.SARS-CoV-2 的年龄特异性死亡率和免疫模式。
Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2.
8
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.德国 COVID-19 患者的神经病理学:一项尸检病例系列研究。
Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.
9
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
10
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.疾病严重程度决定了 COVID-19 患者体内 SARS-CoV-2 特异性中和抗体反应。
Signal Transduct Target Ther. 2020 Sep 2;5(1):180. doi: 10.1038/s41392-020-00301-9.